PLOD1 and polycystic ovary syndrome: Both high-dose BSTJF and FPS-ZM1 restored testosterone (5.1 ± 0.2 and 4.7 ± 0.7 ng/mL) and LH (24.3 ± 4.2 and 23.2 ± 6.1 mU/mL) levels (P < 0.05 vs. PCOS) (Fig. 6A).